The company will instead produce authorized generic versions of the inhalers, which it said will look and work the same but ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...

the form of the drug you’re prescribed (such as the HandiHaler inhaler or Respimat inhaler) These same factors may affect your price for Spiriva if you have insurance. But the price you pay with ...

The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...

In addition to GSK’s generic offerings, there is also a generic metered dose inhaler made by RPK Pharmaceuticals that has the ...

Salmeterol (as xinafoate) 50mcg/inh; dry pwd for inhalation; device with drug in blisters. Serevent Diskus is supplied as a disposable teal green plastic inhaler containing a foil blister strip ...

Albuterol 90mcg/inh; metered-dose aerosol; contains hydrofluoroalkane; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to stimulation ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could ...

awareness of the consequences of generic prescribing of inhalers and specific examples of problems which have arisen. Interviews with community pharmacists will provide data about dispensing ...

Members of the HELP Committee are criticizing drugmakers for charging more for inhalers in the U.S. than in other countries. Improving the Patient Financial Experience Throughout the Patient Journey ...

Drug companies are taking advantage of a global climate treaty to boost profits. The treaty, signed by some 120 countries nearly a decade ago, is now providing inhaler makers with a golden escape ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...